FDA staff concerned about safety of Endo's testosterone injection

(Reuters) - Reviewers for the U.S. Food and Drug Administration said safety data on Endo Health Solutions Inc's twice-rejected testosterone injection Aveed was "concerning" and showed that the therapy was associated with severe and immediate post-injection adverse events.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news